Engaging plasticity: Differentiation therapy in solid tumors
Cancer is a systemic heterogeneous disease that can undergo several rounds of latency and activation. Tumor progression evolves by increasing diversity, adaptation to signals from the microenvironment and escape mechanisms from therapy. These dynamic processes indicate necessity for cell plasticity....
Main Authors: | Neta Bar-Hai, Dana Ishay-Ronen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.944773/full |
Similar Items
-
The role of tumor microenvironment on cancer stem cell fate in solid tumors
by: Sara Razi, et al.
Published: (2023-06-01) -
Promising applications of nanotechnology in inhibiting chemo-resistance in solid tumors by targeting epithelial-mesenchymal transition (EMT)
by: Mona Tangsiri, et al.
Published: (2024-01-01) -
CD73, Tumor Plasticity and Immune Evasion in Solid Cancers
by: Haitang Yang, et al.
Published: (2021-01-01) -
Intertwining of Activin A and TGFβ Signaling: Dual Roles in Cancer Progression and Cancer Cell Invasion
by: Holli A. Loomans, et al.
Published: (2014-12-01) -
Multimodality imaging differentiation of pancreatic neuroendocrine tumors and solid pseudopapillary tumors with a nomogram model: A large single-center study
by: Hai-Feng Hu, et al.
Published: (2022-10-01)